The diabetes drug sotagliflozin significantly reduces the risk of stroke

According to a recent study, sotagliflozin, a drug used to treat diabetes, significantly reduces the risk of stroke and death from cardiovascular causes. What's more, its effects are felt very quickly. Will this drug change cardiovascular risk prevention?